分组1 - Natera reported a quarterly loss of $0.64 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.39, and compared to a loss of $0.26 per share a year ago, indicating a significant earnings surprise of -64.10% [1] - The company achieved revenues of $592.18 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 15.77%, and showing an increase from $439.76 million in the same quarter last year [2] - Natera has surpassed consensus revenue estimates four times over the last four quarters, indicating a positive trend in revenue performance [2] 分组2 - The stock has increased by approximately 26.3% since the beginning of the year, outperforming the S&P 500's gain of 15.6% [3] - The company's earnings outlook is crucial for future stock performance, with current consensus EPS estimates at -$0.33 for the coming quarter and -$1.96 for the current fiscal year [7] - The Zacks Industry Rank places Medical Services in the bottom 40% of over 250 Zacks industries, suggesting that the industry outlook may negatively impact stock performance [8]
Natera (NTRA) Reports Q3 Loss, Beats Revenue Estimates